NCT04699188
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04699188
Title Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation (KontRASt-01)
Acronym KontRASt-01
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | FRA | ESP | DNK | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Emory University School of Medicine-Winship Cancer Institute Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Montreal Quebec H2W 1T8 Canada Details
Novartis Investigative Site Guangzhou Guangdong 510080 China Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Cologne 50937 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Freiburg im Breisgau 79106 Germany Details
Novartis Investigative Site Hong Kong 999077 Hong Kong Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Milan MI 20133 Italy Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Nagoya Aichi-ken 466 8560 Japan Details
Novartis Investigative Site Kashiwa Chiba 277 8577 Japan Details
Novartis Investigative Site Osaka Osaka 541-8567 Japan Details
Novartis Investigative Site Chuo Ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Koto Ku Tokyo 135 8550 Japan Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Málaga Andalusia 29010 Spain Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site L'Hospitalet de Llobregat Catalonia 08907 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Valencia Valencia 46010 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field